Retrograde Intra-renal Surgery, Ureteral Stent-Related Symptom
Conditions
Brief summary
The purpose of this study is to determine if post-operative stent size impacts stent-related pain and discomfort.
Interventions
After surgery, patients will have the Boston Scientific 4.8 Fr ureteral stent placed.
After surgery, patients will have the Bard 7 Fr ureteral stent placed.
Sponsors
Study design
Eligibility
Inclusion criteria
• Patients undergoing a retrograde intra-renal surgery (RIRS) (only patients undergoing the procedure for stone treatment will be included) who will require post-operative indwelling ureteral stent placement on a string at the conclusion of the procedure.
Exclusion criteria
* Patients with intra-operative ureteral injury who will require ureteral stent for extended time (more than 10 days, in that case a stent without a string will be used). * Patient undergoing ureteroscopy for any indication other than stone extraction. * Patients who are currently pregnant as determined by clinical presurgical screening.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain score post ureteroscopy procedure until stent removal determined by the primary operating team. Stent will be on a string | Starting post-operatively, daily, until stent is removed (estimated 7-14 days) | Post-operatively, patient will be contacted by study coordinators every day until stent is removed (usually 7-14 days after the surgery) to scale their stent pain on a scale from 1-5 as following: No pain: 1; Mild pain with no need for additional medication: 2; Mild pain with need for additional medication (anticholinergics): 3; Moderate stent pain (requiring narcotics): 4; Severe stent pain (requiring ER visit): 5. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Volume of post-operative correspondence between patients and medical system. | 14 days | Total number of communications received from patient post-operatively. |
Countries
United States
Contacts
Mayo Clinic